Invention Grant
- Patent Title: Ketoreductase mutant
- Patent Title (中): 酮还原酶突变体
-
Application No.: US13699206Application Date: 2010-05-21
-
Publication No.: US08697409B2Publication Date: 2014-04-15
- Inventor: Fusuke Mazuka , Takayoshi Fukushima , Naomi Sumida , Koji Yanai
- Applicant: Fusuke Mazuka , Takayoshi Fukushima , Naomi Sumida , Koji Yanai
- Applicant Address: JP Tokyo
- Assignee: Meiji Seika Pharma Co., Ltd.
- Current Assignee: Meiji Seika Pharma Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- International Application: PCT/JP2010/058631 WO 20100521
- International Announcement: WO2011/145211 WO 20111124
- Main IPC: C12P19/56
- IPC: C12P19/56

Abstract:
Disclosed are a ketoreductase mutant which can be used for an efficient production of daunorubicin derivatives, a DNA encoding the mutant, a transformant prepared by introducing the DNA thereinto to produce a daunorubicin derivative, and a process of producing a daunorubicin derivative using the transformant. The ketoreductase mutant has an amino acid sequence in which one amino acid residue or two or more amino acid residues selected from the group consisting of amino acids located at positions corresponding to the 42nd, 149th, 153rd, 270th, and 306th amino acids in the amino acid sequence of a ketoreductase (EvaE) from a chlororemomycin-producing bacterium (Amycolatopsis orientalis) are substituted with another amino acid residues.
Public/Granted literature
- US20130116416A1 KETOREDUCTASE MUTANT Public/Granted day:2013-05-09
Information query